Close Menu

NEW YORK (GenomeWeb) – CareDx reported after the close of the market on Thursday that its first quarter revenues rose 21 percent year over year, thanks to momentum from the recent launch of its kidney transplant test Allosure.

For the three months ended March 31, the diagnostics company said revenues rose to $14.1 million from $11.6 million in Q1 2017, beating analysts' average estimate of $13.3 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Financial Times reports the US bolstering its ability to track SARS-CoV-2 alterations.

The New York Times reports that Cedars-Sinai researchers have uncovered a new strain of SARS-CoV-2 in Southern California.

In Nucleic Acids Research this week: pan-cancer atlas focus on miRNA biogenesis mutations, methylation analysis of pig skeletal muscles, and more.

President-elect Joe Biden has nominated Eric Lander to serve as director of the Office of Science and Technology Policy, the Associated Press says.